EDO Reveals 2025's Most Effective TV Ads: Red Lobster, Taco Bell, and Beyoncé-Backed Levi's Lead the Way
As media fragmentation grows and performance pressure intensifies, the most effective marketers are turning to outcome-based insights to inform their strategies. With every media dollar under greater scrutiny, EDO delivers the immediate signals brands need to make smarter creative and media decisions while campaigns are still live.
Each ad in EDO's rankings outperformed its industry peers in driving immediate consumer response — behaviors that are proven to predict future sales. Marketers can look to these standouts for creative inspiration, performance benchmarks, and new ways to activate audiences across Convergent TV.
'Some of the biggest creative wins this year came from brands willing to meet the moment — whether it was Red Lobster rebuilding after bankruptcy, Cadillac stepping into the luxury EV space, or Taco Bell entering QSR's crispy chicken wars,' said Laura Grover, SVP, Head of Client Solutions, EDO. 'These campaigns took different paths and strategies, but all drove measurable consumer engagement that signals intent and powers future business growth.'
Here are some of the top trends from EDO's list. For a deeper dive into all 15 categories — including Alcohol, Breakfast, Credit Cards, Cruises, Insurance, OTC Pain Relief, Snacks, and Travel — visit edo.com/topads.
Apparel: Levi's reached No. 1 featuring Beyoncé, while Mott & Bow, New Balance, Vuori, and Tecovas each landed two ads in the top 10.
Automotive: In the Luxury Automotive category, Cadillac's 2025 Escalade IQ ranked No. 1, with Acura and Lexus also showing a strong presence. Among Non-Luxury advertisers, GMC led with the Hummer EV and its Crabwalk feature, while Toyota and Ford secured multiple top ads, including NFL-backed campaigns.
CPG Beauty: Dove led with uplifting ads focused on confidence and self-care, followed by Gold Bond, Neutrogena, No7, and Lancôme with celebrity-backed campaigns.
Diabetes & Weight Management: Noom claimed eight of the top 10 spots promoting GLP-1 drugs and health advice, with Hims' GLP-1-focused ad outperforming the category by 522%.
Restaurants: In Casual Dining, Red Lobster landed five of the top creatives, boosted by NBA vet Blake Griffin and NSYNC's Joey Fatone, alongside Applebee's, Outback Steakhouse, and Buffalo Wild Wings, focusing on meals under $20. Meanwhile, in the QSR category, Taco Bell dominated with top ads spotlighting its Luxe Cravings Box and the debut of its crispy chicken, while Long John Silver's and McDonald's also engaged with value and pop culture themes.
'Great creatives drive real business outcomes by inspiring viewers to take action,' continued Grover. 'This year's top ads used bold visuals, humor, music, and culturally resonant moments to spark meaningful response.'
How Brands Use EDO to Maximize TV ROI
EDO makes it easy to optimize media and creative strategy across linear and streaming TV. The company's Creative Rotation Optimization tool helps advertisers detect, compare, and improve performance while campaigns are still live.
About EDO
EDO is the TV outcomes company. Our leading measurement platform connects convergent TV airings to the ad-driven consumer behaviors most predictive of future sales. EDO empowers the advertising industry to maximize media impact, optimize creative performance, and know the fair value of every impression — across linear and streaming for an increasingly programmatic world. By combining immediate engagement signals with world-class decision science and vertical AI, EDO equips industry leaders with syndicated, investment-grade data that aligns media to business results — with detailed competitive, category, and historical insights. Leading brands, agencies, networks, streamers, and studios trust EDO's TV intelligence to know what works.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval
Cash truly is king. On Monday, shares in Novo Nordisk jumped 4% after the drugmaker announced that US customers who pay out-of-pocket will be able to buy its blockbuster diabetes drug Ozempic for less than half the list price. In a year of struggles against copycats, an emboldened chief rival and political pressure over high prices, executives are no doubt hoping the discount will prove a crowning achievement. READ ALSO: SoftBank Acquires a 2% Stake in Embattled Intel and Brokers Chafe Under Abrupt Expansion of Steel, Aluminum Tariffs A Letter from Washington Without insurance, Ozempic can set back US customers roughly $1,350 a month, or enough to rent a one-bedroom apartment in Kansas City (where the local barbecue might have you in need of a GLP-1 prescription). That hefty price tag has led to a bipartisan pushback in Washington, including from President Donald Trump, who sent a letter to Novo last month demanding executives lower prices for their company's treatments. Trump also urged drugmakers to develop direct-to-consumer sales models for their medicines. Americans spent $98 billion out of pocket on prescriptions last year, a 25% cumulative increase over five years, according to IQVIA, while a majority worry that prescription costs are unaffordable, according to KFF polling. Meanwhile, Novo has its own incentives to lower prices. For one, customers flocked to cheaper copycat drugs that exploded in popularity during a multi-year GLP-1 shortage, one that the FDA declared over earlier this year. And the company's chief rival in the GLP-1 space, Mounjaro- and Zepbound-maker Eli Lilly, has been binge-eating market share. Last month, the pressure prompted Novo to slash its sales and profit forecasts, prompting a massive selloff on Wall Street (shares are down 37% this year). On Monday, the company signalled it will defend its turf: Novo said cash-paying Americans can now buy Ozempic for $499 per month through its official website, its patient assistance program, its newly launched direct-to-consumer online pharmacy, or through discount telehealth platform GoodRx. The move follows Novo's decision to halve the price of weight-loss treatment Wegovy in March. Its price reductions follow similar cuts from Eli Lilly, which slashed the prices of both its weight loss and obesity GLP-1 drugs in March. David Ricks, Eli Lilly's CEO, said at the time that about 10% of the 1 million people who bought Zepbound did so from the company's website. MASHing Success: Monday's news came on the heels of a Friday victory for Novo, when Wegovy received FDA approval to treat metabolic dysfunction-associated steatohepatitis (MASH), a liver condition that affects roughly 5% of US adults, potentially opening up a market of millions of new customers. It was the first GLP-1 treatment to be approved for MASH, giving Novo a leg up against its biggest competitor. Rival Lilly, meanwhile, has run trials, inked deals and even made an acquisition earlier this year with an eye to rolling out MASH treatments. This post first appeared on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter.
Yahoo
2 hours ago
- Yahoo
New Solana Launchpad, Token Mill, Bets Traders (Mostly) Care Only About Price Pumps
An upcoming token launchpad on Solana plans to drive usership and volumes to its platform by focusing on one thing it says matters most to microcap traders: Token prices going up. Put fair launches, creator fees and community-friendly features in the backseat. Token Mill, which launches on Thursday at 16:00 UTC, comes with a design that doesn't try to be fairer or cheaper. It instead focuses on the volatility of tokens when they are issued, giving traders a reason to use the service and drive fees for the platform in doing so. Token Mill comes from the team behind Avalanche-focused Joe and Mantle-focused Merchant Moe. In 2021, Trader Joe was among the largest decentralized exchange (DEX) by volume and mindshare, but has taken a hit in user base after a general migration of liquidity and users away from Avalanche in favor of Solana and newer ecosystems, such as Base. Solana's the leader of token issuance platforms, has been nearly untouchable since its inception in early 2024. The platform's stripped-down model — instant token creation, immediate liquidity, and a flat 1% fee — generated an estimated $800 million in annual revenue and became the cycle's killer app. Competitors like BagsApp, and HeavenDex tried to win market share with revenue share schemes and buyback promises, but each faded after a brief surge. At the center of Token Mill is a mechanic called King of the Mill. Tokens are divided into three market-cap tiers — Bronze ($50,000–$250,000), Silver ($250,000–$1 million) and Gold ($1 million–$10 million). Every 30 minutes, tokens in each tier battle for the crown, with the winner decided by trading volume in the final minutes of the round. The twist is that platform fees from that round are used to buy and burn the winning token, creating a feedback loop of visibility and price spikes. The pitch is that one big runner can trigger a chain of smaller ones. Each race attracts more traders chasing the crown, each crown generates new fees, and each buy-and-burn sets the stage for the next pump. In theory, the wheel never stops turning. 'The nature of this flywheel also means one big runner is enough to generate a dozen smaller ones, creating an ecosystem where everyone eats,' founder @cryptofishx wrote on X. 'Trickle down economics.' Token Mill also adds its own spin on bonding curves. Rather than forcing a token to migrate midway through its lifecycle, the platform combines two Uniswap v3-style pools into a single curve: one that runs until 80% of the supply is minted, and another that activates afterward to mimic a graduation phase. The aim is to carry tokens from launch to maturity without interruption The question is whether any of this can dent dominance. But Token Mill is betting that if the volatility loop works as intended, it can carve out space in an ecosystem where every trader is hunting the next runner. 'Every 30 minutes, this cycle resets meaning there's always another opportunity for a runner to emerge. The more tokens compete, the more volume flows, the stronger the pumps, and the faster the flywheel spins,' Token Mill's announcement read. But Solana's trenches have seen plenty of experiments come and go. Whether this flywheel spins long enough to matter will be tested the moment the first crowns are claimed. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
The Lamborghini Fenomeno in Photos
More from Robb Report 'It Needs Cinematic Drama': Lamborghini's Design Director on the 1,065 HP Fenomeno The Lucid Gravity X Reimagines the Electric SUV as an All-Terrain Beast Cadillac's Elevated Velocity Concept Wants to Take the Performance SUV to New Heights Best of Robb Report The 2024 Chevy C8 Corvette: Everything We Know About the Powerful Mid-Engine Beast The World's Best Superyacht Shipyards The ABCs of Chartering a Yacht Click here to read the full article. The Lamborghini Fenomeno, the marque's most powerful V-12 model to date. 'We give adrenaline a shape,' says Mitja Borkert, Lamborghini's design director, regarding the Fenomeno. Though the interior roughly mimics the Revuelto's cockpit, it adds a few delightfully, and absurdly, sinister elements. The new hard-shell racing seats have a retro-modern styling and feature strategically placed pads. The Fenomeno's airflow management allows for an improvement of 30 percent in both aero load and cooling compared to that of the Revuelto. The Fenomeno's widened and lengthened body—when compared to the Revuelto—has been designed in a very graphical way, with fewer lines, broad shoulders and surfaces, a long tail, and a peaky front. The car is claimed to cover zero to 62 mph in 2.4 seconds on its way to a top speed of 217 mph. Only 29 examples are being built for Lamborghini's most valued customers, along with one more for the automaker's museum. Each Fenomeno starts at $3.5 million.
